NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (âKSFâ) are investigating the proposed sale of Performant Healthcare, Inc. (NasdaqGS: PHLT) to Machinify. Under the terms of the proposed transaction, shareholders of Performant will receive $7.75 in cash for each share of Performant that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate
Related Questions
What impact might the news have on trading volume and liquidity of PHLT shares in the near term?
What is the probability that the transaction will be delayed or abandoned because of the investigation?
Could the potential findings of inadequacy in price or process lead to a renegotiated purchase price or deal termination?
How does the $7.75 per share offer compare to recent trading ranges and to valuations of comparable companies?
What are the possible regulatory or legal outcomes from KahnâŻSwickâŻ&âŻFotiâs inquiry, and how might they affect shareholder value?
How might the outcome affect the valuation of comparable M&A deals in the healthcare sector?
Could other bidders emerge if the current deal is challenged, and how would that affect the transaction price?
How will the uncertainty and potential legal costs impact PHLTâs shortâterm stock volatility?
What are the potential upside or downside scenarios for PHLT shareholders if the deal is halted versus if it proceeds as announced?
How might the investigation by the former Louisiana Attorney General affect the likelihood of the sale closing?